Table 3 Charlson index comorbidities (%) for study cohorts
From: Predictive performance of comorbidity measures in administrative databases for diabetes cohorts
Comorbidity | Cohort 1a(n= 29,058 ) | Cohort 2 (n= 41,925) |
|---|---|---|
Diabetes, without complications | 15.5 | 15.3 |
Chronic pulmonary disease | 14.0 | 13.7 |
Congestive heart failure | 8.0 | 8.1 |
Cancer | 5.5 | 5.8 |
Cerebrovascular disease | 5.5 | 4.7 |
Myocardial infarction | 2.5 | 3.0 |
Diabetes, with complications | 2.3 | 2.5 |
Peptic ulcer disease | 2.0 | 1.7 |
Renal disease | 1.9 | 3.2 |
Peripheral vascular disease | 1.4 | 1.6 |
Metastatic carcinoma | 1.3 | 1.8 |
Connective tissue disease | 0.8 | 0.8 |
Dementia | 0.8 | 0.9 |
Mild liver disease | 0.6 | 0.6 |
Paraplegia and hemiplegia | 0.6 | 0.4 |
Moderate or severe liver disease | 0.1 | 0.2 |
AIDS/HIV | <0.1 | <0.1 |
1 or more Charlson comorbidities | 39.1 | 37.2 |